Rowan Digital Works - Rowan-Virtua Research Day: Effects of the Non-Stimulant Norepinephrine Reuptake Inhibitor, Atomoxetine, on Cognitive Flexibility in Healthy Adult Long-Evans Rats
 

College

Rowan-Virtua School of Osteopathic Medicine

Keywords

Behavior, Pharmacological, Cognitive Flexibility, Atomoxetine

IRB or IACUC Protocol Number

IACUC: 2020-1194

Date of Presentation

5-1-2025 12:00 AM

Poster Abstract

Executive function is the control of multiple higher order cognitive processes that include attention, working memory, and cognitive flexibility. Cognitive flexibility is the ability to shift behavioral strategies

in response to changing environmental demands and task complexity. This cognitive modality is often impaired in many neuropsychiatric disorders like attention deficit hyperactivity disorder (ADHD). Deficits in cognitive flexibility are associated with dysregulation of the catecholamines, norepinephrine (NE) and dopamine (DA) within the prefrontal cortex (PFC). Atomoxetine (ATX), a non-stimulant NE reuptake inhibitor, elevates levels of NE and DA in the PFC by inhibiting the norepinephrine transporter (NET). ATX is used to treat ADHD and improves components of cognitive flexibility in rodent models of cognitive disorder. However, the effects of ATX on cognitive flexibility in healthy adult rats have not been demonstrated. Within the current study, an automated operant strategy shifting task (SST) of cognitive flexibility was used to examine the effects of ATX (0.3-1mg/kg) on performance in male and female Long-Evans rats. Rats initially acquired a visual cue strategy to collect sucrose reward pellets. Twenty-four hours after initial acquisition, rats were assessed for retrieval of the visual cue strategy followed by a series of strategy shifting and reversal learning challenges.

Disciplines

Behavior and Behavior Mechanisms | Cognitive Neuroscience | Disease Modeling | Medicine and Health Sciences | Neuroscience and Neurobiology | Organic Chemicals

Share

COinS
 
May 1st, 12:00 AM

Effects of the Non-Stimulant Norepinephrine Reuptake Inhibitor, Atomoxetine, on Cognitive Flexibility in Healthy Adult Long-Evans Rats

Executive function is the control of multiple higher order cognitive processes that include attention, working memory, and cognitive flexibility. Cognitive flexibility is the ability to shift behavioral strategies

in response to changing environmental demands and task complexity. This cognitive modality is often impaired in many neuropsychiatric disorders like attention deficit hyperactivity disorder (ADHD). Deficits in cognitive flexibility are associated with dysregulation of the catecholamines, norepinephrine (NE) and dopamine (DA) within the prefrontal cortex (PFC). Atomoxetine (ATX), a non-stimulant NE reuptake inhibitor, elevates levels of NE and DA in the PFC by inhibiting the norepinephrine transporter (NET). ATX is used to treat ADHD and improves components of cognitive flexibility in rodent models of cognitive disorder. However, the effects of ATX on cognitive flexibility in healthy adult rats have not been demonstrated. Within the current study, an automated operant strategy shifting task (SST) of cognitive flexibility was used to examine the effects of ATX (0.3-1mg/kg) on performance in male and female Long-Evans rats. Rats initially acquired a visual cue strategy to collect sucrose reward pellets. Twenty-four hours after initial acquisition, rats were assessed for retrieval of the visual cue strategy followed by a series of strategy shifting and reversal learning challenges.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.